Skip to main content
OpenTrials

Clinical trial discovery

Find Clinical Trials

Search studies by condition, treatment, location, eligibility, or trial identifier.

Showing 1–20 of 165 trials

Active filters

Clinical trials found

Published and searchable clinical trials

Searching for clinical trials...
Recruiting

Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

NCT01555892

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +10 more
Locations
  • Harris Health System (includes ben Taub General Hospital and Smith) Houston, Texas, United States
  • Houston Methodist Hospital Houston, Texas, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details
Recruiting

Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

NCT06667687

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations
  • Carolina BioOncology Institute /ID# 265259 Huntersville, North Carolina, United States
  • Willamette Valley Cancer Institute and Research Center /ID# 270945 Eugene, Oregon, United States
  • Texas Oncology - Central/South Texas /ID# 270946 Austin, Texas, United States
  • START Mountain Region /ID# 267592 West Valley City, Utah, United States
View all 14 locations
View Trial Details
Recruiting

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

NCT02848274

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford University, School of Medicine Palo Alto, California, United States
  • University of Iowa Iowa City, Iowa, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View all 13 locations
View Trial Details
Completed

An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma

NCT01592370

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations
  • Local Institution - 0035 Clovis, California, United States
  • Division Of Hematology & Oncology Ctr. For Health Sciences Los Angeles, California, United States
  • Local Institution - 0012 Los Angeles, California, United States
  • Local Institution - 0017 Aurora, Colorado, United States
View all 43 locations
View Trial Details
Completed

Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers

NCT00788684

Conditions
CD20-Positive Lymphoid Malignancies, Chronic Lymphoid Leukemia, Hematologic Diseases, +16 more
Locations
  • University of Arizona Cancer Center - North Campus /ID# 16721 Tucson, Arizona, United States
  • Stanford University School of Med /ID# 9782 Stanford, California, United States
  • Cleveland Clinic Main Campus /ID# 9784 Cleveland, Ohio, United States
  • Univ of Wisconsin Hosp/Clinics /ID# 21701 Madison, Wisconsin, United States
View Trial Details
Completed

Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma

NCT01755975

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Saint Francis/Mount Sinai Regional Cancer Center Hartford, Connecticut, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center at Commack Commack, New York, United States
View Trial Details
Completed

Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies

NCT03955783

Conditions
Acute Myeloid Leukemia, Diffuse Large B-cell Lymphoma, Hematologic Diseases, +15 more
Locations
  • Roswell Park Cancer Center Buffalo, New York, United States
  • University Hospitals of Cleveland Cleveland, Ohio, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Completed

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

NCT00285259

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +37 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of South Florida Tampa, Florida, United States
View all 22 locations
View Trial Details
Completed

Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma

NCT00596154

Conditions
CNS Brain Cancer, CNS Lymphoma, Hemic and Lymphatic Diseases, +9 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details